Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Diagnostic confusion in round cell sarcomas has increased due to rapid advancements.
• Next-generation sequencing has identified novel gene fusions, leading to new classifications.
• The 5th edition of the WHO Classification recognizes distinct molecular subgroups of round cell sarcomas.

Purpose of the Study:

• To differentiate Ewing sarcoma from other round cell sarcomas.
• To highlight key clinical, pathologic, and molecular distinctions.
• To aid in the recognition and management of rare round cell malignancies.

Main Methods:

• Review of current literature and diagnostic criteria.
• Analysis of clinicopathologic, molecular, and prognostic features.
• Comparison of Ewing sarcoma with CIC-rearranged, BCOR-altered, and EWSR1-non-ETS fusion sarcomas.

Main Results:

• Four distinct molecular subgroups of undifferentiated round cell sarcomas are now recognized beyond Ewing sarcoma.
• Each molecular subtype exhibits unique clinical and prognostic profiles.
• Despite diagnostic improvements, challenges in identification and treatment persist.

Conclusions:

• Accurate diagnosis of round cell sarcomas relies on integrating clinical, pathologic, and molecular data.
• Understanding the differences between Ewing sarcoma and other round cell sarcomas is crucial for effective patient care.
• Further research is needed to refine treatment strategies for these distinct entities.